Advertisement
Organisation › Details
Sterna Biologicals (Genova) (Group)
Sterna biologicals GmbH & Co. KG is an innovative clinical-stage immunology company developing novel treatments for chronic inflammatory diseases such as asthma, chronic obstructive pulmonary disease (COPD), atopic dermatitis, and ulcerative colitis. By targeting transcription factors that play a central role in regulating Th1- and Th2-driven inflammatory mechanisms, the Company's proprietary DNAzyme-based drug candidates can intervene with key inflammatory processes to address related diseases more effectively. Sterna currently has four programs in phase 2 development. *
Start | 2012-12-07 existent | |
Industry | BIOTECH | |
Person | Pangratz, Christian M. (Atriva Therapeutics 202301– CEO before Sterna Biologicals + Secarna + Vectura + Sykepharma) | |
Person 2 | Renz, Jonas (Secarna + Genova + Sterna Biologicals 201604 Managing Director) | |
Region | Marburg | |
Country | Germany | |
Street | 7 Bismarckstr. | |
City | 35037 Marburg | |
Tel | +49-6421-9830050 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Sterna Biologicals GmbH & Co. KG. (5/26/20). "Press Release: Sterna Biologicals Secures EUR 12.0 Million (approx. USD 13.0 Million) in Private Placement". Marburg. | ||
Record changed: 2023-12-30 |
Advertisement
More documents for Sterna Biologicals (Genova) (Group)
- [1] Atriva Therapeutics GmbH. (11/9/22). "Press Release: Atriva Therapeutics Appoints Christian Pangratz as Chief Executive Officer, Implementing Planned Management Change". Tübingen, Frankfurt a.M. & Martinsried....
- [2] Sterna Biologicals GmbH & Co. KG. (1/7/21). "Press Release: Sterna Biologicals Raises further EUR 10.0 Million (approx. USD 11.9 Million) in Series A – 2nd Closing Private Placement". Marburg....
- [3] Sterna Biologicals GmbH & Co. KG. (5/26/20). "Press Release: Sterna Biologicals Secures EUR 12.0 Million (approx. USD 13.0 Million) in Private Placement". Marburg....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top